Thyroxine Half-Life and Once-Daily Dosing
Thyroxine (levothyroxine/T4) has a half-life of approximately 6-7 days in euthyroid individuals, which directly enables once-daily dosing by maintaining stable serum levels throughout the 24-hour period. 1
Pharmacokinetic Rationale for Once-Daily Dosing
The extended half-life of levothyroxine is the fundamental reason for its convenient once-daily administration schedule. Due to the long half-life of levothyroxine, the peak therapeutic effect at a given dose may not be attained for 4-6 weeks 1. This prolonged half-life means:
- A single daily dose maintains relatively constant serum levels over 24 hours
- Missing an occasional dose causes minimal disruption to thyroid hormone levels
- Dose adjustments require 4-8 weeks to reach steady-state before reassessment 2
Key Pharmacokinetic Parameters
The FDA label specifies that T4 has a half-life of 6-7 days in euthyroidism, though this varies with thyroid status:
- 3-4 days in hyperthyroidism (faster metabolism)
- 9-10 days in hypothyroidism (slower metabolism) 1
This is in stark contrast to T3 (triiodothyronine), which has a half-life of ≤2 days and would require twice-daily dosing 1, 3.
Clinical Implications
Absorption and Timing
Approximately 70% of oral levothyroxine is absorbed, primarily from the jejunum and upper ileum 2. Levothyroxine should be taken in the morning on an empty stomach, at least 30-60 minutes before breakfast, or at bedtime 4 hours after the last meal 2, 1. The long half-life means that even with variable absorption timing, steady-state levels remain relatively stable.
Dose Monitoring Timeline
Because of the 6-7 day half-life:
- TSH should be checked 4-8 weeks after initiating therapy or dose adjustments 2
- Smaller dose adjustments (12.5-25 µg) may require 8 weeks or longer before TSH plateaus 2
- Once stable, monitoring can occur at 6-month then 12-month intervals 2
Practical Advantages of Long Half-Life
The extended half-life provides several clinical benefits:
- Forgiveness for missed doses: Occasional non-compliance doesn't immediately destabilize thyroid status 3
- Stable hormone levels: Avoids the peaks and troughs seen with shorter-acting preparations
- Simplified dosing regimen: Once-daily administration improves compliance compared to multiple daily doses
- Predictable dose adjustments: Changes can be made methodically with adequate time between assessments
Common Pitfall
A critical error is checking TSH too early after dose initiation or adjustment. The long half-life means steady-state is not achieved for 4-6 weeks, so premature testing leads to inappropriate dose changes and prolonged time to optimal replacement 1. Always wait the full 4-8 weeks before reassessing thyroid function tests.
The 6-7 day half-life of levothyroxine is the pharmacokinetic foundation that makes once-daily dosing both practical and effective for hypothyroidism management.